13F HOLDINGS REPORT
Lion Point Capital, LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001013594-25-001032
Total Value
$14.7M
Positions
19
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | FENNEC PHARMACEUTICALS INC | FENC | 195,700 | $1.6M | 11.03% |
| 2 | ARDELYX INC | ARDX | 335,400 | $1.3M | 8.93% |
| 3 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 45,900 | $1.3M | 8.62% |
| 4 | BRIDGEBIO PHARMA INC | BBIO | 26,000 | $1.1M | 7.62% |
| 5 | INSMED INC | INSM | 10,650 | $1.1M | 7.28% |
| 6 | MINERALYS THERAPEUTICS INC | MLYS | 79,000 | $1.1M | 7.26% |
| 7 | MILESTONE PHARMACEUTICALS IN | MIST | 548,806 | $1.1M | 7.23% |
| 8 | AVADEL PHARMACEUTICALS PLC | G29687103 | 98,700 | $873,495 | 5.93% |
| 9 | JASPER THERAPEUTICS INC | JSPRW | 146,500 | $813,075 | 5.52% |
| 10 | BENITEC BIOPHARMA INC | BNTC | 62,000 | $725,400 | 4.93% |
| 11 | GERON CORP | GERN | 500,000 | $705,000 | 4.79% |
| 12 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 46,300 | $649,126 | 4.41% |
| 13 | DISC MEDICINE INC | IRON | 10,600 | $561,376 | 3.81% |
| 14 | SYNDAX PHARMACEUTICALS INC | SNDX | 55,000 | $515,075 | 3.50% |
| 15 | REGENXBIO INC | RGNX | 57,750 | $474,128 | 3.22% |
| 16 | BIOHAVEN LTD | BHVN | 22,700 | $320,297 | 2.17% |
| 17 | MERSANA THERAPEUTICS INC | 59045L106 | 644,000 | $190,624 | 1.29% |
| 18 | SERES THERAPEUTICS INC | MCRB | 17,038 | $189,292 | 1.29% |
| 19 | HUMACYTE INC | HUMAW | 83,500 | $174,515 | 1.18% |